Breaking News Instant updates and real-time market news.

RETA

Reata Pharmaceuticals

$100.37

4.57 (4.77%)

09:20
10/15/19
10/15
09:20
10/15/19
09:20

Reata Pharmaceuticals price target raised to $162 from $105 at Baird

Baird analyst Brian Skorney raised his price target to $162 from $105 following news its omaveloxolone hit the primary endpoint in MOXle, a place controlled study in Friedreich's ataxia. The study was a major surprise and may now push towards blockbuster status. Skorney reiterated his Outperform rating on Reata Pharmaceuticals shares.

RETA Reata Pharmaceuticals
$100.37

4.57 (4.77%)

10/10/19
STFL
10/10/19
NO CHANGE
Target $135
STFL
Buy
Reata Pharmaceuticals 'bold move' should be well received by Street, says Stifel
Stifel analyst Adam Walsh notes that in "a bold move" likely to be well received by the Street, Reata Pharmaceuticals (RETA) reacquired ex-U.S. rights to BARD, OMAV, and other Nrf2 activators from AbbVie (ABBV) for total deal consideration of $330M. Given AbbVie's lack of a significant renal franchise, the reacquisition of ex-U.S. BARD rights restores strategic flexibility to Reata and provides the opportunity to either find a more engaging development partner, go it alone ex-U.S., or sell the company outright, he contends. Further, the analyst believes the deal terms look "highly reasonable" relative to potential ex-U.S. BARD sales. Walsh has a Buy rating and $135 price target on Reata's shares.
10/14/19
LEER
10/14/19
NO CHANGE
Target $180
LEER
Outperform
Reata Pharmaceuticals price target raised to $180 form $139 at SVB Leerink
SVB Leerink analyst Joseph Schwartz raised his price target for Reata Pharmaceuticals to $180 from $139, while reiterating an Outperform rating on the shares. The analyst believes Bardoxolone methyl remains a key growth driver for Reata with Phase.3 CARDINAL data expected near-term. Additional analysis since his CARDINAL preview suggests that a positive CARDINAL outcome has the potential to lift the stock by 25%-50% and that a valuation of $4B-$7B is reasonable post-data. Lastly, although Phase 3 CARDINAL data are expected after American Society of Nephrology Kidney Week, emerging evidence continues to dispel concerns of hyperfiltration, he contends.
10/15/19
SBSH
10/15/19
NO CHANGE
Target $241
SBSH
Buy
Reata shares worth $241 after 'unequivocal upside win,' says Citi
Citi analyst Yigal Nochomovitz raised his price target for Reata Pharmaceuticals to $241 from $194 and reiterates the stock as a top pick with a Buy rating. The stock in premarket trading is up 34%, or $34.43, to $135.02. The registrational Part 2 portion of the MOXIe Phase 2 trial of omaveloxolone in patients with Friedreich's ataxia is a "best case scenario," Nochomovitz tells investors in a research note. The data are an "unequivocal upside win" for Reata, especially amidst very low expectations for the trial, says the analyst. He sees omaveloxolone as a $40-$50 per share opportunity for the company and moved his valuation to a 90% probability of success. This means Reata is now worth $241 per share, says the analyst.
10/15/19
CANT
10/15/19
NO CHANGE
Target $180
CANT
Overweight
Reata Pharmaceuticals price target raised to $180 from $125 at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan raised his price target for Reata Pharmaceuticals to $180 from $125 saying the company last night announced favorable top-line data for its registrational MOXIe trial in Friedreich's ataxia. Though this win "is clearly a surprise" given that no drugs are approved in Friedreich's ataxia, MOXIe's superior design, enriched enrollment criteria, and powering set it up with a non-zero probability for a positive outcome, Duncan tells investors in a research note. The analyst now sees omaveloxolone as a source of "significant" potential revenue following a new drug appliaction in late 2020 and possible launch in late 2021. He reiterates an Overweight rating on Reata Pharmaceuticals.

TODAY'S FREE FLY STORIES

TGT

Target

$110.50

-0.09 (-0.08%)

15:37
11/19/19
11/19
15:37
11/19/19
15:37
Technical Analysis
Technical Preview: Target before earnings has a potential bearish pattern »

On the daily chart there…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BRY

Berry Petroleum

$8.61

-2.695 (-23.84%)

15:36
11/19/19
11/19
15:36
11/19/19
15:36
Hot Stocks
Breaking Hot Stocks news story on Berry Petroleum »

Berry Petroleum says CA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$367.88

-1.62 (-0.44%)

15:35
11/19/19
11/19
15:35
11/19/19
15:35
Hot Stocks
Boeing says working on enhancements that address NTSB recommendations »

Boeing issue the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESE

Esco Technologies

$86.89

2.12 (2.50%)

15:34
11/19/19
11/19
15:34
11/19/19
15:34
Options
ESCO Technologies options imply 8.1% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

DIS

Disney

$148.53

0.88 (0.60%)

15:31
11/19/19
11/19
15:31
11/19/19
15:31
Periodicals
Disney sees $100M domestic opening weekend for 'Frozen 2,' Bloomberg says »

Disney said it anticipate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$13.98

7.96 (132.23%)

15:28
11/19/19
11/19
15:28
11/19/19
15:28
Recommendations
Myovant Sciences analyst commentary  »

Myovant Sciences price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ACM

Aecom

$42.75

0.11 (0.26%)

15:26
11/19/19
11/19
15:26
11/19/19
15:26
Conference/Events
Aecom participates in a conference call with BofA/Merrill »

Aecom discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$150.52

0.17 (0.11%)

15:20
11/19/19
11/19
15:20
11/19/19
15:20
Hot Stocks
Microsoft's Mixer says Partners now can gate ability to clip streams »

Microsoft's (MSFT)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 09

    Dec

ALC

Alcon

$59.24

0.35 (0.59%)

15:19
11/19/19
11/19
15:19
11/19/19
15:19
Options
Alcon options imply 6.2% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 02

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/19/19
11/19
15:17
11/19/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
11/19/19
11/19
15:16
11/19/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFN

Infinera

$6.63

-0.17 (-2.50%)

15:15
11/19/19
11/19
15:15
11/19/19
15:15
Options
Infinera put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

HD

Home Depot

$226.30

-12.68 (-5.31%)

15:10
11/19/19
11/19
15:10
11/19/19
15:10
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 11

    Dec

URBN

Urban Outfitters

$28.49

-1.67 (-5.54%)

15:04
11/19/19
11/19
15:04
11/19/19
15:04
Options
Urban Outfitters options imply 18.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 05

    Dec

CRON

Cronos Group

$6.87

0.74 (12.07%)

, MO

Altria Group

$47.20

-1.14 (-2.36%)

14:57
11/19/19
11/19
14:57
11/19/19
14:57
Periodicals
Altria Group filing points to increased Cronos stake, Canadian Insider says »

A post to the website…

CRON

Cronos Group

$6.87

0.74 (12.07%)

MO

Altria Group

$47.20

-1.14 (-2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

GRUB

GrubHub

$40.59

-0.42 (-1.02%)

, UBER

Uber

$27.06

0.3 (1.12%)

14:55
11/19/19
11/19
14:55
11/19/19
14:55
Hot Stocks
Food delivery service DoorDash sued by DC attorney general on tip policy »

Washington, D.C. Attorney…

GRUB

GrubHub

$40.59

-0.42 (-1.02%)

UBER

Uber

$27.06

0.3 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 21

    Nov

  • 04

    Dec

BRY

Berry Petroleum

$10.23

-1.075 (-9.51%)

14:54
11/19/19
11/19
14:54
11/19/19
14:54
Recommendations
Berry Petroleum analyst commentary  »

Berry Petroleum shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRY

Berry Petroleum

$10.23

-1.075 (-9.51%)

, HAL

Halliburton

$19.94

-0.21 (-1.04%)

14:49
11/19/19
11/19
14:49
11/19/19
14:49
Periodicals
CA governor stops approval of new fracking pending review, L.A. Times says »

California Governor Gavin…

BRY

Berry Petroleum

$10.23

-1.075 (-9.51%)

HAL

Halliburton

$19.94

-0.21 (-1.04%)

BHGE

Ticker changed to BKR

$0.00

(0.00%)

CJ

C&J Energy Services

$0.00

(0.00%)

XOM

Exxon Mobil

$67.91

-0.6 (-0.88%)

CHK

Chesapeake

$0.56

-0.085 (-13.20%)

DVN

Devon Energy

$21.52

-0.44 (-2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

PAGS

PagSeguro Digital

$37.06

-0.79 (-2.09%)

14:49
11/19/19
11/19
14:49
11/19/19
14:49
Options
PagSeguro Digital options imply 12.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 17

    Dec

ET

Energy Transfer LP

$11.22

-0.105 (-0.93%)

14:45
11/19/19
11/19
14:45
11/19/19
14:45
Options
Energy Transfer call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHE

Benchmark Electronics

$33.59

-0.05 (-0.15%)

14:40
11/19/19
11/19
14:40
11/19/19
14:40
Downgrade
Benchmark Electronics rating change  »

Benchmark Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

KSS

Kohl's

$47.23

-11.16 (-19.11%)

14:37
11/19/19
11/19
14:37
11/19/19
14:37
Downgrade
Kohl's rating change  »

Kohl's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 05

    Dec

FB

Facebook

$199.49

2.04 (1.03%)

14:34
11/19/19
11/19
14:34
11/19/19
14:34
Periodicals
Facebook caters to young users with meme-making app Whale, Information says »

As part of an effort to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

GOOG

Alphabet

$1,314.83

-3.62 (-0.27%)

, GOOGL

Alphabet Class A

$1,313.48

-6.69 (-0.51%)

14:21
11/19/19
11/19
14:21
11/19/19
14:21
Periodicals
Google admits to underreporting on UK political ads, Guardian says »

The Guardian's Alex…

GOOG

Alphabet

$1,314.83

-3.62 (-0.27%)

GOOGL

Alphabet Class A

$1,313.48

-6.69 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$199.38

1.93 (0.98%)

14:21
11/19/19
11/19
14:21
11/19/19
14:21
Hot Stocks
Facebook says F8 conference to take place May 5-6 »

Facebook announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.